Sign In
Buy CTSO
$0.489
+0.0090 (+1.88%)
At Close: Jun 03, 2026
CytoSorbents Reports Third Quarter 2023 Financial and Operational Results
04:15pm, Thursday, 09'th Nov 2023
Q3 2023 Product sales grew 20% to $7.8M versus $6.5M in Q3 2022. Q3 2023 Total revenue was approximately $8.8M. The pivotal STAR-T trial remains blinded with database lock nearing and initial data ana
CytoSorbents to Report Third Quarter 2023 Operating and Financial Results
07:00am, Friday, 27'th Oct 2023
PRINCETON, N.J., Oct. 27, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery usin
CytoSorbents to Present at the 8th Annual Dawson James Conference
07:00am, Thursday, 05'th Oct 2023
PRINCETON, N.J., Oct. 05, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery usin
Cytosorbents Corporation (CTSO) Q2 2023 Results Earnings Conference Call
09:25pm, Tuesday, 01'st Aug 2023
Cytosorbents Corporation. (NASDAQ:CTSO ) Q2 2023 Earnings Conference Call August 1, 2023 4:30 PM ET Company Participants Taylor Devlin - Revenue Accountant Phillip Chan - Chief Executive Officer Vince
CytoSorbents to Report Second Quarter 2023 Operating and Financial Results
07:00am, Wednesday, 26'th Jul 2023
PRINCETON, N.J., July 26, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery usin
Cytosorbents Corporation (CTSO) Q1 2023 Earnings Call Transcript
10:11pm, Tuesday, 02'nd May 2023
Cytosorbents Corporation (NASDAQ:CTSO ) Q1 2023 Results Earnings Conference Call May 2, 2023 4:30 AM ET Company Participants Taylor Devlin - Revenue Accountant Phillip Chan - Chief Executive Officer K
Cytosorbents Corporation (CTSO) Q4 2022 Earnings Call Transcript
11:32pm, Thursday, 09'th Mar 2023
Cytosorbents Corporation (NASDAQ:CTSO ) Q4 2022 Earnings Conference Call March 9, 2023 4:30 PM ET Company Participants Jodi Hoover – Manager-Clinical Administration Phillip Chan – Chief Executive
CytoSorbents to Report Fiscal 2022 Operating and Financial Results
07:00am, Friday, 24'th Feb 2023
MONMOUTH JUNCTION, N.J. , Feb. 24, 2023 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surger
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
08:07am, Monday, 07'th Nov 2022 Benzinga
Gainers
Peak Bio, Inc. (NASDAQ: PKBO) shares surged 105.8% to close at $7.82 on Friday. Peak Bio reported closing of up to $100 million common stock purchase transaction with White Lion Capital. Lade
CytoSorbents Corporation (CTSO) Q3 2022 Earnings Call Transcript
06:20pm, Saturday, 05'th Nov 2022
CytoSorbents Corporation (NASDAQ:CTSO ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Michelle Almonte - Executive Assistant to CEO Phillip Chan - Chief Executive O
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
04:54pm, Friday, 04'th Nov 2022 Benzinga
Gainers
Peak Bio, Inc. (NASDAQ: PKBO) jumped 115% to $8.17. Peak Bio reported closing of up to $100 million common stock purchase transaction with White Lion Capital. Ladenburg Thalmann initiated cov
Why Starbucks Shares Are Trading Higher; Here Are 43 Stocks Moving Premarket
12:35pm, Friday, 04'th Nov 2022 Benzinga
Gainers
Sentage Holdings Inc. (NASDAQ: SNTG) shares rose 67.7% to $5.10 in pre-market trading after jumping 24% on Thursday.
BioAtla, Inc. (NASDAQ: BCAB) rose 47.5% to $9.38 in pre-market trading aft
CytoSorbents (CTSO) Reports Q3 Loss, Misses Revenue Estimates
09:49pm, Thursday, 03'rd Nov 2022
CytoSorbents (CTSO) delivered earnings and revenue surprises of -75% and 9.78%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
CytoSorbents to Report Third Quarter 2022 Operating and Financial Results
07:00am, Thursday, 27'th Oct 2022
PRINCETON, N.J. , Oct. 27, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using b
Why fuboTV Shares Are Trading Higher By 11%; Here Are 22 Stocks Moving Premarket
10:52am, Tuesday, 18'th Oct 2022 Benzinga
Gainers
COMSovereign Holding Corp. (NASDAQ: COMS) shares rose 78.1% to $0.0787 in pre-market trading after gaining 4% on Monday.
Zovio Inc (NASDAQ: ZVO) rose 60.2% to $0.2311 in pre-market trading af
